S&P 500   4,071.70
DOW   34,429.88
QQQ   292.55
Today Only: Get a 4K Camera Drone for Just $80
The Small Biotech Scaring Big Pharma (Ad)
Pentagon debuts its new stealth bomber, the B-21 Raider
Why CSL Ltd Stock Could Be Worth a Look
Tiny $4 Company to “Steal” Billions From Tesla?  (Ad)
Group of Seven nations and Australia join EU in setting $60-per-barrel price cap on Russian oil
EXPLAINER: What's the effect of Russian oil price cap, ban?
Tiny $4 Company to “Steal” Billions From Tesla?  (Ad)
MarketBeat: Week in Review 11/28 – 12/02
Estonia to buy US rocket artillery system in $200M deal
S&P 500   4,071.70
DOW   34,429.88
QQQ   292.55
Today Only: Get a 4K Camera Drone for Just $80
The Small Biotech Scaring Big Pharma (Ad)
Pentagon debuts its new stealth bomber, the B-21 Raider
Why CSL Ltd Stock Could Be Worth a Look
Tiny $4 Company to “Steal” Billions From Tesla?  (Ad)
Group of Seven nations and Australia join EU in setting $60-per-barrel price cap on Russian oil
EXPLAINER: What's the effect of Russian oil price cap, ban?
Tiny $4 Company to “Steal” Billions From Tesla?  (Ad)
MarketBeat: Week in Review 11/28 – 12/02
Estonia to buy US rocket artillery system in $200M deal
S&P 500   4,071.70
DOW   34,429.88
QQQ   292.55
Today Only: Get a 4K Camera Drone for Just $80
The Small Biotech Scaring Big Pharma (Ad)
Pentagon debuts its new stealth bomber, the B-21 Raider
Why CSL Ltd Stock Could Be Worth a Look
Tiny $4 Company to “Steal” Billions From Tesla?  (Ad)
Group of Seven nations and Australia join EU in setting $60-per-barrel price cap on Russian oil
EXPLAINER: What's the effect of Russian oil price cap, ban?
Tiny $4 Company to “Steal” Billions From Tesla?  (Ad)
MarketBeat: Week in Review 11/28 – 12/02
Estonia to buy US rocket artillery system in $200M deal
S&P 500   4,071.70
DOW   34,429.88
QQQ   292.55
Today Only: Get a 4K Camera Drone for Just $80
The Small Biotech Scaring Big Pharma (Ad)
Pentagon debuts its new stealth bomber, the B-21 Raider
Why CSL Ltd Stock Could Be Worth a Look
Tiny $4 Company to “Steal” Billions From Tesla?  (Ad)
Group of Seven nations and Australia join EU in setting $60-per-barrel price cap on Russian oil
EXPLAINER: What's the effect of Russian oil price cap, ban?
Tiny $4 Company to “Steal” Billions From Tesla?  (Ad)
MarketBeat: Week in Review 11/28 – 12/02
Estonia to buy US rocket artillery system in $200M deal
NYSEAMERICAN:SENS

Senseonics - SENS Stock Forecast, Price & News

$1.17
+0.01 (+0.86%)
(As of 12/2/2022 12:00 AM ET)
Add
Compare
Today's Range
$1.12
$1.18
50-Day Range
$1.10
$2.23
52-Week Range
$0.77
$3.89
Volume
1.85 million shs
Average Volume
6.74 million shs
Market Capitalization
$559.56 million
P/E Ratio
5.57
Dividend Yield
N/A
Price Target
$3.00

Senseonics MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
156.4% Upside
$3.00 Price Target
Short Interest
Bearish
14.29% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
Decreasing
From $0.31 to ($0.15) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.71 out of 5 stars

SENS stock logo

About Senseonics (NYSEAMERICAN:SENS) Stock

Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management for a period of up to six months. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. The company has a collaboration agreement with the University Hospitals Accountable Care Organization. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.

Receive SENS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Senseonics and its competitors with MarketBeat's FREE daily newsletter.

SENS Stock News Headlines

Senseonics Announces CFO Transition - Business Wire
Senseonics Announces CFO Transition
See More Headlines
Receive SENS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Senseonics and its competitors with MarketBeat's FREE daily newsletter.

SENS Company Calendar

Last Earnings
11/08/2022
Today
12/03/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Process Control Instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NYSEAMERICAN:SENS
Previous Symbol
NASDAQ:SENS
CIK
N/A
Employees
89
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$3.00
High Stock Price Forecast
$3.00
Low Stock Price Forecast
$3.00
Forecasted Upside/Downside
+156.4%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Net Income
$-302,470,000.00
Net Margins
2,317.41%
Pretax Margin
2,317.40%

Debt

Sales & Book Value

Annual Sales
$13.68 million
Book Value
($0.42) per share

Miscellaneous

Free Float
450,553,000
Market Cap
$559.56 million
Optionable
Optionable
Beta
0.95

Key Executives

  • Dr. Timothy T. Goodnow (Age 60)
    Pres, CEO & Director
    Comp: $1.07M
  • Dr. Mukul Jain (Age 49)
    Chief Operating Officer
    Comp: $640.66k
  • Dr. Francine Ratner Kaufman M.D. (Age 71)
    Chief Medical Officer & Director
    Comp: $658.44k
  • Mr. Frederick T. Sullivan (Age 41)
    CFO & Principal Accounting Officer
  • Mr. Kenneth L. Horton (Age 55)
    Gen. Counsel & Corp. Devel. Advisor













SENS Stock - Frequently Asked Questions

Should I buy or sell Senseonics stock right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Senseonics in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" SENS shares.
View SENS analyst ratings
or view top-rated stocks.

What is Senseonics' stock price forecast for 2023?

2 equities research analysts have issued twelve-month price objectives for Senseonics' stock. Their SENS share price forecasts range from $3.00 to $3.00. On average, they anticipate the company's stock price to reach $3.00 in the next year. This suggests a possible upside of 156.4% from the stock's current price.
View analysts price targets for SENS
or view top-rated stocks among Wall Street analysts.

How have SENS shares performed in 2022?

Senseonics' stock was trading at $2.88 on January 1st, 2022. Since then, SENS stock has decreased by 59.4% and is now trading at $1.17.
View the best growth stocks for 2022 here
.

How were Senseonics' earnings last quarter?

Senseonics Holdings, Inc. (NYSEAMERICAN:SENS) announced its quarterly earnings data on Tuesday, November, 8th. The company reported ($0.13) EPS for the quarter, missing analysts' consensus estimates of ($0.04) by $0.09. The business earned $4.62 million during the quarter, compared to analysts' expectations of $4.06 million. Senseonics had a net margin of 2,317.41% and a negative trailing twelve-month return on equity of 132.13%.

What guidance has Senseonics issued on next quarter's earnings?

Senseonics issued an update on its FY 2022 earnings guidance on Tuesday, November, 8th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $15.00 million-$17.00 million, compared to the consensus revenue estimate of $16.41 million.

What other stocks do shareholders of Senseonics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Senseonics investors own include VirnetX (VHC), Advanced Micro Devices (AMD), Micron Technology (MU), Nabriva Therapeutics (NBRV), Sorrento Therapeutics (SRNE), Amarin (AMRN), Tandem Diabetes Care (TNDM), CytoDyn (CYDY), TransEnterix (TRXC) and TherapeuticsMD (TXMD).

What is Senseonics' stock symbol?

Senseonics trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "SENS."

Who are Senseonics' major shareholders?

Senseonics' stock is owned by many different retail and institutional investors. Top institutional investors include BlackRock Inc. (6.55%), Vanguard Group Inc. (4.70%), State Street Corp (2.36%), Renaissance Technologies LLC (0.39%), Nuveen Asset Management LLC (0.34%) and Bank of New York Mellon Corp (0.32%). Insiders that own company stock include Anthony R Raab, Douglas A Roeder, Douglas S Prince, Edward Fiorentino, Francine Kaufman, Mirasol Panlilio, Mukul Jain, Nick B Tressler, Stephen P Defalco and Timothy T Goodnow.
View institutional ownership trends
.

How do I buy shares of Senseonics?

Shares of SENS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Senseonics' stock price today?

One share of SENS stock can currently be purchased for approximately $1.17.

How much money does Senseonics make?

Senseonics (NYSEAMERICAN:SENS) has a market capitalization of $559.56 million and generates $13.68 million in revenue each year. The company earns $-302,470,000.00 in net income (profit) each year or $0.21 on an earnings per share basis.

How can I contact Senseonics?

Senseonics' mailing address is 20451 Seneca Meadows Pkwy, GERMANTOWN, MD 20876-7005, United States. The official website for the company is www.senseonics.com. The company can be reached via phone at (301) 515-7260, via email at investors@senseonics.com, or via fax at 301-515-0988.

This page (NYSEAMERICAN:SENS) was last updated on 12/3/2022 by MarketBeat.com Staff